Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation
Fertility and Sterility Sep 16, 2017
Pereira N, et al. - This trial strived to compare the oocyte and embryo yield related to GnRH-agonist triggers vs. hCG triggers in cancer patients, who were undergoing controlled ovarian stimulation (COS) for fertilization preservation. Increased number of metaphase II (MII) oocytes and 2PN embryos available for cryopreservation was discovered through the use of a GnRH-agonist trigger in the study cohort.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
